NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 25 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,000 | – | 405 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 405 | -86.8% | 0.00% | – |
| Q1 2015 | $3,000 | +200.0% | 3,075 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -96.7% | 3,075 | -55.6% | 0.00% | – |
| Q3 2014 | $30,000 | -11.8% | 6,925 | 0.0% | 0.00% | – |
| Q2 2014 | $34,000 | -8.1% | 6,925 | 0.0% | 0.00% | – |
| Q1 2014 | $37,000 | -14.0% | 6,925 | -2.8% | 0.00% | – |
| Q4 2013 | $43,000 | -8.5% | 7,125 | 0.0% | 0.00% | – |
| Q3 2013 | $47,000 | +123.8% | 7,125 | +75.9% | 0.00% | – |
| Q2 2013 | $21,000 | – | 4,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|